Advertisement
Singapore markets close in 2 hours 48 minutes

  • Straits Times Index

    3,276.98
    -16.15 (-0.49%)
     

  • Nikkei

    37,630.04
    -830.04 (-2.16%)
     

  • Hang Seng

    17,214.19
    +12.92 (+0.08%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    64,252.89
    -2,383.22 (-3.58%)
     

  • CMC Crypto 200

    1,390.07
    +7.50 (+0.54%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,330.10
    -8.30 (-0.35%)
     

  • Crude Oil

    82.91
    +0.10 (+0.12%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,570.29
    -1.19 (-0.08%)
     

  • Jakarta Composite Index

    7,157.23
    -17.30 (-0.24%)
     

  • PSE Index

    6,578.62
    +5.87 (+0.09%)
     

Company News for Jun 27, 2022

Zacks Equity Research
·1-min read

  • Shares of CarMax, Inc. KMX jumped 7.2% after the company reported first-quarter 2022 earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.51 per share.

  • Kanzhun Limited’s BZ shares surged 9.5% after the company reported first-quarter 2022 earnings of $0.04 per share, surpassing the Zacks Consensus Estimate of $0.02 per share.

  • Shares of FedEx Corporation FDX soared 7.2% after the company reported fourth-quarter fiscal 2022 revenues of $24,394 million, outpacing the Zacks Consensus Estimate of $24,281.7 million.

  • Seagen Inc.’s SGEN gained 3.1% on reports that Merck & Co., Inc. MRK is making efforts to acquire the biotech company.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
 
FedEx Corporation (FDX) : Free Stock Analysis Report
 
CarMax, Inc. (KMX) : Free Stock Analysis Report
 
Seagen Inc. (SGEN) : Free Stock Analysis Report
 
KANZHUN LIMITED Sponsored ADR (BZ) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research